stockrowBristol Myers Squibb Company (BMY) vs GSK PLC Sponsored ADR (GSK)
- Bristol Myers Squibb Company BMY 62.12 −1.60%
- GSK PLC Sponsored ADR GSK 50.31 −0.20%
Bristol Myers Squibb Company and GSK PLC Sponsored ADR are both Drug Manufacturers General companies. Bristol Myers Squibb Company is the larger, with a market value of $129.0B against $101.0B — 1.3× the size. Bristol Myers Squibb Company trades at the lower P/E: 13.7× against 16.7×. GSK PLC Sponsored ADR grew revenue faster over the last twelve months: 6.90% against 4.16%. Bristol Myers Squibb Company has the higher net margin (18.5% vs 13.0%) and the higher return on invested capital (13.2% vs 9.61%). Both pay a dividend; Bristol Myers Squibb Company yields more (4.06% vs 3.61%). Across the 23 metrics below, GSK PLC Sponsored ADR leads on 12 and Bristol Myers Squibb Company on 11.
Valuation
Profitability
| Metric | BMY | GSK | Drug Manufacturers General median |
|---|---|---|---|
| Gross margin | 69.24% | 72.64% | 73.01% |
| Operating margin | 22.65% | 17.95% | 18.34% |
| Net margin | 18.47% | 13.02% | 7.31% |
| Free cash flow margin | 18.56% | 19.65% | 18.56% |
| Return on equity | 44.01% | 25.48% | 5.80% |
| Return on assets | 9.96% | 6.53% | 2.28% |
| Return on invested capital | 13.19% | 9.61% | 6.26% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack